Biofrontera Inc. (BFRIW) shareholders
BFRIWNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BFRI
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 10/30
$0.00+0.00 (0.00%)
Close on Oct 30, 2026Market cap $12.96MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
0M
Shares held, 13F filers
Institutional holders
5
0 new, 1 sold out
Net institutional buying
-0M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Rosalind Advisors, Inc. Joint filing with Salamon Steven A J (9.90%), Aharon Gil (9.90%) and 1 more | 16,801,629 | 9.90% | 13G (passive) amendment | Jun 30, 2026 |
| Aharon Gil Joint filing with Rosalind Advisors, Inc. (9.90%), Salamon Steven A J (9.90%) and 1 more | 16,777,017 | 9.90% | 13G (passive) amendment | Oct 27, 2025 |
| Rosalind Master Fund L.P. Joint filing with Rosalind Advisors, Inc. (9.90%), Salamon Steven A J (9.90%) and 1 more | 9,886,969 | 9.90% | 13G (passive) amendment | Mar 31, 2025 |
| Delphi Unternehmensberatung Aktiengesellschaft Joint filing with Wilhelm Konrad Thomas Zours (19.99%), Deutsche Balaton Aktiengesellschaft (19.99%) and 5 more | 2,552,230 | 19.99% | 13D (active) amendment | Sep 16, 2025 |
| Orin Hirschman Joint filing with AIGH Capital Management LLC (7.90%) | 915,210 | 7.90% | 13G (passive) amendment | Dec 31, 2025 |
| AIGH Capital Management LLC Joint filing with Orin Hirschman (9.90%) | 884,563 | 9.90% | 13G (passive) amendment | Dec 31, 2024 |
| The Hewlett Fund LP | 504,168 | 9.90% | 13G (passive) | Feb 22, 2024 |
| Alexander Link Joint filing with Deutsche Balaton Aktiengesellschaft (5.92%), VV Beteiligungen Aktiengesellschaft (5.92%) and 3 more | 458,884 | 5.92% | 13D (active) amendment | Dec 20, 2024 |
| Bigger Capital Fund, LP | 10,000 | – | 13G (passive) amendment | Sep 30, 2024 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of BFRIW | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Bard Associates Inc | 154,900 | – | $4.17K | – | 0.00% |
| Clear Street Group Inc. | 9,044 | – | $243 | – | 0.00% |
| Osaic Holdings, Inc. | 1,100 | – | $33 | – | 0.00% |
| US Bancorp \de\ | 1,000 | – | $27 | – | 0.00% |
| UBS Group AG | 342 | – | $9 | −1 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|
| Q2 2026 | 5 | 0M | 0 / 0 | 1 / 1 | 0M | 0M |
| Q1 2026 | 6 | 0M | 0 / 1 | 1 / 0 | 0M | 0M |
| Q4 2025 | 6 | 0M | 1 / 1 | 0 / 0 | 0M | 0M |
| Q3 2025 | 5 | 0M | 1 / 1 | 0 / 1 | 0M | 0M |
| Q2 2025 | 6 | 0M | 1 / 0 | 3 / 1 | 0M | 0M |
| Q1 2025 | 6 | 0M | 1 / 0 | 2 / 0 | 0M | 0M |
| Q4 2024 | 5 | 0M | 0 / 0 | 2 / 1 | 0M | 0M |
| Q3 2024 | 6 | 0M | 1 / 2 | 0 / 1 | 0M | 0M |
| Q2 2024 | 6 | 0M | 0 / 1 | 2 / 1 | 0M | 0M |
| Q1 2024 | 7 | 0M | 1 / 1 | 3 / 1 | 0M | 0M |
| Q4 2023 | 7 | 0M | 0 / 2 | 1 / 0 | 0M | 0M |
| Q3 2023 | 7 | 0M | 3 / 1 | 2 / 0 | 0M | 0M |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | Latest filing |
|---|---|---|---|
| Hermann Luebbert | CEO & Chairman, Director | 352,711 | Jul 29, 2026 |
| Eugene Frederick Leffler | Chief Financial Officer | 206,250 | Jul 29, 2026 |
| George Patrick Jones | Chief Commercial Officer | – | Mar 6, 2026 |
| Beth J. Hoffman | Director | – | Mar 6, 2026 |
| Kevin Daniel Weber | Director | – | Mar 6, 2026 |
| Heikki Lanckriet | Director | – | Mar 6, 2026 |
| John J. Borer Iii | Director | – | Mar 6, 2026 |
| la Huerta Martinez Maria del Pilar de | Director, 10% owner | 400,000 | Sep 25, 2025 |
| AG Biofrontera | Director, 10% owner | 400,000 | Sep 18, 2025 |
| Hansjoerg Plaggemars | 10% owner | – | Sep 30, 2025 |
| Beteiligungen Aktiengesellschaft VV | 10% owner | 458,884 | Sep 30, 2025 |
| Christian Alexander Ansgar Link | 10% owner | – | Sep 30, 2025 |
| Unternehmensberatung Aktiengesellschaft Delphi | 10% owner | 458,884 | Sep 30, 2025 |
| Balaton Aktiengesellschaft Deutsche | 10% owner | 458,884 | Sep 26, 2025 |
| Wilhelm Konrad Thomas Zours | 10% owner | 458,884 | Sep 26, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Eugene Frederick Leffler Chief Financial Officer | Jul 28, 2026 | Option exercise | +31,250 | – | – | 206,250 |
| Hermann Luebbert CEO & Chairman, Director | Jul 28, 2026 | Option exercise | +62,500 | – | – | 352,711 |
| Eugene Frederick Leffler Chief Financial Officer | Mar 5, 2026 | Option exercise | +87,500 | – | – | 175,000 |
| Hermann Luebbert CEO & Chairman, Director | Mar 5, 2026 | Option exercise | +137,500 | – | – | 290,211 |
| Eugene Frederick Leffler Chief Financial Officer | Sep 10, 2025 | Option exercise | +87,500 | – | – | 87,500 |
| Hermann Luebbert CEO & Chairman, Director | Sep 10, 2025 | Option exercise | +137,500 | – | – | 152,711 |
| Hermann Luebbert CEO & Exec. Chairman, Director | May 18, 2024 | Option exercise | +4,771 | – | – | 15,211 |
| Erica L. Monaco Chief Executive Officer | May 18, 2023 | Option exercise | +76,336 | – | – | 133,025 |
| Hermann Luebbert Executive Chairman, Director | May 18, 2023 | Option exercise | +95,420 | – | – | 208,799 |
| Hermann Luebbert Executive Chairman, Director | Aug 22, 2022 | Option exercise | +113,379 | – | – | 113,379 |
| Erica L. Monaco Chief Executive Officer | Jul 1, 2022 | Option exercise | +56,689 | – | – | 56,689 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 15, 2026 (FINRA, reported twice a month)
Short % of shares outstanding
–
0M shares short
Days to cover
1.0
At 0M shares a day
Change since last report
-18.9%
From 0M shares
Short volume, 20 days
32.9%
Of volume reported to FINRA
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Biofrontera's stock actually held short. No settlement fails above the SEC's reporting threshold in the last 90 days.